Nutzen Sie La Quotidienne de Bruxelles mit personalisierter Werbung, Werbetracking, Nutzungsanalyse und externen Multimedia-Inhalten. Details zu Cookies und Verarbeitungszwecken sowie zu Ihrer jederzeitigen Widerrufsmöglichkeit finden Sie unten, im Cookie-Manager sowie in unserer Datenschutzerklärung.
Use La Quotidienne de Bruxelles with personalised advertising, ad tracking, usage analysis and external multimedia content. Details on cookies and processing purposes as well as your revocation option at any time can be found below, in the cookie manager as well as in our privacy policy.
Utilizar La Quotidienne de Bruxelles con publicidad personalizada, seguimiento de anuncios, análisis de uso y contenido multimedia externo. Los detalles sobre las cookies y los propósitos de procesamiento, así como su opción de revocación en cualquier momento, se pueden encontrar a continuación, en el gestor de cookies, así como en nuestra política de privacidad.
Utilisez le La Quotidienne de Bruxelles avec des publicités personnalisées, un suivi publicitaire, une analyse de l'utilisation et des contenus multimédias externes. Vous trouverez des détails sur les cookies et les objectifs de traitement ainsi que sur votre possibilité de révocation à tout moment ci-dessous, dans le gestionnaire de cookies ainsi que dans notre déclaration de protection des données.
Utilizzare La Quotidienne de Bruxelles con pubblicità personalizzata, tracciamento degli annunci, analisi dell'utilizzo e contenuti multimediali esterni. I dettagli sui cookie e sulle finalità di elaborazione, nonché la possibilità di revocarli in qualsiasi momento, sono riportati di seguito nel Cookie Manager e nella nostra Informativa sulla privacy.
Utilizar o La Quotidienne de Bruxelles com publicidade personalizada, rastreio de anúncios, análise de utilização e conteúdo multimédia externo. Detalhes sobre cookies e fins de processamento, bem como a sua opção de revogação em qualquer altura, podem ser encontrados abaixo, no Gestor de Cookies, bem como na nossa Política de Privacidade.
Swedish paleogeneticist Svante Paabo, who won the Nobel Medicine Prize on Monday for using DNA to reveal the link between humans and Neanderthals, drew early inspiration from his Nobel laureate father.
Text size:
However Paabo later learned that his father had been living a "double life", and his existence had been kept a secret from his father's other family.
Paabo, 67, was awarded the medicine Nobel for a long list of achievements including sequencing the Neanderthal genome for the first time and discovering the existence of a distant human relative called the Denisovans.
He was born in Stockholm in 1955 to Estonian chemist Karin Paabo and Sune Bergstrom, a biochemist who won the Nobel Medicine Prize in 1982. His father died in 2004.
In his 2014 memoir "Neanderthal Man: In Search of Lost Genomes", Paabo wrote that he gained inspiration to study medicine at Sweden's Uppsala University from his father, who had previously been a medical doctor.
Later he learned that his father "had two families, one of which did not know about the other," he wrote.
"I had grown up as the secret extra-marital son of Sune Bergstrom," Paabo wrote, adding that he had "only occasionally" seen his father as an adult.
Paabo also followed in his father's footsteps by studying biochemistry, earning a PhD at Uppsala University for using DNA research to study a protein of adenovirus, common viruses which cause cold-like symptoms.
But Paabo had long been fascinated with mummies and "could not quite shake off my romantic fascination with ancient Egypt," he wrote in his memoir.
- An impossible task -
The crossover of his medical research using DNA and preoccupation with mummies put him on the path that would become his life's work.
"Could it be possible to study ancient DNA sequences and thereby clarify how ancient Egyptians were related to one another and to people today?" he asked in his book.
"Such questions were breathtaking. Surely they must have already occurred to someone else."
Finding that they had not, Paabo sought his own answers.
It proved a difficult task, because there are only trace amounts of DNA left in ancients remains.
He first made international news in 1985, when he published research that found a DNA fragment in the mummy of a 2,400-year-old child.
Paabo then turned his focus toward Neanderthals when he was recruited by Germany's Munich University in 1995.
A year later, he managed to sequence some mitochondrial DNA from a 40,000-year-old piece of Neanderthal bone.
He then became the head of the genetics department at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany.
He accomplished the "seemingly impossible task" of publishing the first Neanderthal genome sequence in 2010, according to a statement from the Nobel Assembly.
The research surprised by the scientific world by showing that Neanderthal genomes are still present in one to four percent of humans from European or Asian descent.
"We find traces of their DNA everywhere," Paabo told AFP in 2018.
- 'Normal human beings' -
Also in 2010, Paabo and his team revealed the existence of Denisovans, an extinct human relative, just by sequencing the DNA from a 40,000-year-old finger bone.
Only a year before these breakthroughs were published, Paabo developed potentially life-threatening blood clots in his lungs.
While researching his illness, "to my amazement I stumbled upon references to my father's work in 1943", Paabo wrote in his memoir.
His father had "elucidated the chemical structure of herapain," the drug "which had perhaps saved my life," he wrote.
In an interview published by the Nobels on Monday, he said that having a Nobel-winning parent may have also given him confidence by showing that "such people are normal human beings and it's not such an amazing thing".
"You don't put your parents on a pedestal," he added.
He now identifies as bisexual and has two children with primatologist Linda Vigilant, who also works at the Max Planck Institute.